A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.
Clinical trial NCT01522196 · TERMINATED
Trial details
- NCT number
- NCT01522196
- Sponsor
- Anthera Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2012-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.